Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.
about
Pharmacometabolomic signature of ataxia SCA1 mouse model and lithium effectsR-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5Bipolar disorder and mechanisms of action of mood stabilizersSynaptic polarity depends on phosphatidylinositol signaling regulated by myo-inositol monophosphatase in Caenorhabditis elegansTwo PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activationChanges in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositidesCoupling between inositol 1,4,5-trisphosphate receptors and human transient receptor potential channel 1 when intracellular Ca2+ stores are depletedNeuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithiumStructure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptorsCalbindin D28k targets myo-inositol monophosphatase in spines and dendrites of cerebellar Purkinje neuronsStructure of inositol monophosphatase, the putative target of lithium therapySelective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonismPharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescensReview of pharmacological treatment in mood disorders and future directions for drug development.Phosphoinositides: tiny lipids with giant impact on cell regulationThe crystal structure and mechanism of 1-L-myo-inositol- 1-phosphate synthaseThe structure of the 1L-myo-inositol-1-phosphate synthase-NAD+-2-deoxy-D-glucitol 6-(E)-vinylhomophosphonate complex demands a revision of the enzyme mechanismInhibitors of inositol monophosphataseLithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patientsLithium modifies convulsions and brain phosphoinositide turnover induced by organophosphatesCloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnoverThe action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombinDifferential effect of temperature on histamine- and carbachol-stimulated inositol phospholipid breakdown in slices of guinea-pig cerebral cortexStable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterizationIgA from HIV+ haemophilic patients triggers intracellular signals coupled to the cholinergic system of the intestineAtrial natriuretic factor stimulates exocrine pancreatic secretion in the rat through NPR-C receptorsLuteinizing hormone stimulates the formation of inositol trisphosphate and cyclic AMP in rat granulosa cells. Evidence for phospholipase C generated second messengers in the action of luteinizing hormoneOverexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammationLithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.Inositol phospholipid metabolism during and following synaptic activation: role of adenosine.Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.Neurobiological findings in bipolar II disorder compared with findings in bipolar I disorder.Inositol monophosphatase is a highly conserved enzyme having localized structural similarity to both glycerol 3-phosphate dehydrogenase and haemoglobin.Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 teslaC2-ceramide and reactive oxygen species inhibit pituitary adenylate cyclase activating polypeptide (PACAP)-induced cyclic-AMP-dependent signalling pathway.In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.Membrane depolarization and carbamoylcholine stimulate phosphatidylinositol turnover in intact nerve terminals.Activation of host phospholipases C and D in macrophages after infection with Listeria monocytogenes
P2860
Q21559578-EABCE139-12DB-40D2-95AF-F26BCAF35CB4Q21560784-C7C87A5F-E12C-4731-83AE-9F663EDBB658Q22252332-42B6378D-E755-44C5-88F2-DB427AE9E303Q22336987-41047C83-7C09-4ACF-848B-434D5A0CE4EAQ24317773-C98BE497-9905-49A2-A2C5-1C97C54F3DCCQ24529828-5D51EEC2-5CA4-47EF-8F47-EA4F8550AD8FQ24532142-F4A0A250-C95E-4865-BCE4-C3EF65FCA0AAQ24547141-811F77AF-8E41-4E06-BA1D-82B83696CB28Q24548810-68A6F28F-0FE7-48BB-89E6-31086A27922FQ24555720-34A4F811-8CFB-4E98-8673-5F635EE668F4Q24563510-D15A99BB-05F9-40F0-9F6E-2D91EFC1A141Q24674309-63AD9519-D7A6-43A0-9B96-A15C28F639ADQ24685701-1AB24DBC-E743-466C-8933-CFF5AC58E082Q26853509-40444F4E-41E9-4439-A5D3-412B04B5D962Q27012953-0196BF20-18AA-480A-83B9-1E79EA8A0630Q27637191-1F53FF3A-2390-442C-933D-52CC144F2728Q27642804-0680218F-96C3-40EF-BC44-A9D82F441A89Q28141986-D7C2EC30-9AA8-4CAF-A9D0-D577F8C55947Q28279000-130E5764-2297-4777-BA1D-119700458FAFQ28321848-0DDC3281-EA93-4336-85D8-25E4D9F7A8E2Q28359870-D41C0AD0-0A4D-4148-97DC-5349F1481E9CQ28361275-4D1A844F-E5A3-4173-8F0F-C3F4558B4C9BQ28362215-73996347-CDE5-4A91-A319-5074E2CCA20AQ28379142-E4011A67-7692-445D-B242-01A59177AD61Q28379215-B436BFF2-2D1A-469C-863B-ECD90A46EAF1Q28570879-B2179977-D81E-43AB-A571-56DE20EDEB7FQ28577272-56E9E199-C6F6-4F60-B72A-BFBE520EF383Q28580058-D13F6C7F-17F5-42E6-BCA8-7985295DDF4BQ30427997-7347C45D-A137-4BEA-83B3-2D1087EF9E6FQ30460411-ECAF5A6D-C0BE-4E84-8FC0-1C2A6140343CQ30980756-77BBF7D7-0BFE-45F7-A8BE-4267AD0A80C8Q30981655-292CE541-9BBA-4AD4-B36C-3BB9083810B5Q30984239-D784F8F2-26A6-4E3A-868A-25E4F6A05B94Q30995022-40C8B3B0-F643-4858-8245-3E4CED27BD65Q31036476-4A31DC9E-C6DD-4D3C-8228-490B12B1EC1CQ31832217-205E2401-87FB-4DEA-AAF1-F77E0C93C7CAQ32115381-C6B59A8D-7EC7-41CE-86C6-E1A572060CD6Q33536778-D52BBA1B-4FA5-480D-82CC-B858DB0572FFQ33568426-F6A93968-C5E9-43A9-AE81-EB77311F3AB7Q33592106-F601E5ED-E65B-4B31-BD29-A341ADDAD912
P2860
Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Lithium amplifies agonist-depe ...... in brain and salivary glands.
@en
type
label
Lithium amplifies agonist-depe ...... in brain and salivary glands.
@en
prefLabel
Lithium amplifies agonist-depe ...... in brain and salivary glands.
@en
P2093
P2860
P356
P1433
P1476
Lithium amplifies agonist-depe ...... in brain and salivary glands.
@en
P2093
P2860
P304
P356
10.1042/BJ2060587
P407
P577
1982-09-01T00:00:00Z